NDC 0574-0292

amiloride hydrocloride

Amiloride Hydrocloride

amiloride hydrocloride is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Paddock Laboratories, Llc. The primary component is Amiloride Hydrochloride.

• Product ID: 0574-0292_49fe906d-eefd-40aa-89d8-3c74b50bd59f
• NDC: 0574-0292
• Product Type: Human Prescription Drug
• Proprietary Name: amiloride hydrocloride
• Generic Name: Amiloride Hydrocloride
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2009-04-06
• Marketing Category: NDA / NDA
• Application Number: NDA018200
• Labeler Name: Paddock Laboratories, LLC
• Substance Name: AMILORIDE HYDROCHLORIDE
• Active Ingredient Strength: 5 mg/1
• Pharm Classes: Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0574-0292-01

100 TABLET in 1 BOTTLE (0574-0292-01)

• Marketing Start Date: 2009-04-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0574-0292-01 [00574029201]

amiloride hydrocloride TABLET

• Marketing Category: NDA
• Application Number: NDA018200
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2009-04-06

Drug Details

Active Ingredients

Ingredient	Strength
AMILORIDE HYDROCHLORIDE	5 mg/1

OpenFDA Data

• SPL SET ID: 2b70cf0c-45be-428f-b396-5001ed4e30fc
• Manufacturer:
  • Paddock Laboratories, LLC
• UNII:
  • FZJ37245UC
• RxNorm Concept Unique ID - RxCUI:
  • 977880

Pharmacological Class

• Decreased Renal K+ Excretion [PE]
• Increased Diuresis [PE]
• Potassium-sparing Diuretic [EPC]
• Decreased Renal K+ Excretion [PE]
• Increased Diuresis [PE]
• Potassium-sparing Diuretic [EPC]